ONC
BeOne Medicines Ltd.Company with tickers: ONC, BEIGF
CIK
1651308
CUSIP
07725L102
Shares Outstanding
94,900,812
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 1,313 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 1,729 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 1,274 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Other | 318,370 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 133 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 101 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Convert | 98 |
| 2026-05-13 | Lee Chan Henry | SVP, General Counsel | Sell | 332 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Sell | 332 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 1,274 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 1,729 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 98 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 1,313 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 133 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Convert | 101 |
| 2026-04-08 | Lee Chan Henry | SVP, General Counsel | Other | 318,370 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Sell | 341 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,430 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 98 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Other | 318,370 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,729 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 110 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 133 |
| 2026-03-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,274 |
| 2026-03-06 | Lee Chan Henry | SVP, General Counsel | Award | 65,390 |
| 2026-03-06 | Lee Chan Henry | SVP, General Counsel | Award | 29,874 |
| 2026-03-06 | Wang Lai | President, Global Head of R&D | Award | 55,029 |
| 2026-03-06 | Wang Lai | President, Global Head of R&D | Award | 112,606 |
| 2026-03-06 | Wang Lai | President, Global Head of R&D | Other | 0 |
| 2026-03-06 | Wang Lai | President, Global Head of R&D | Other | 601,965 |
| 2026-03-06 | Wu Xiaobin | President and COO | Award | 168,922 |
| 2026-03-06 | Wu Xiaobin | President and COO | Other | 12,365 |
| 2026-03-06 | Wu Xiaobin | President and COO | Award | 78,624 |
| 2026-03-06 | Wu Xiaobin | President and COO | Other | 4,000 |
| 2026-03-06 | Rosenberg Aaron | Chief Financial Officer | Award | 40,573 |
| 2026-03-06 | Rosenberg Aaron | Chief Financial Officer | Award | 79,014 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Other | 481,533 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Award | 326,976 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Other | 102,188 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Other | 28,204,115 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Other | 7,699,158 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Other | 9,545,000 |
| 2026-03-06 | OYLER JOHN | Director, Chief Executive Officer | Award | 117,936 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 6,526 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Other | 223,106 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 496 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 502 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 6,448 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 8,606 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Convert | 662 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Sell | 664 |
| 2026-02-04 | Lee Chan Henry | SVP, General Counsel | Sell | 996 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 266 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Other | 223,106 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 196 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 3,458 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 202 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 2,548 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Convert | 2,626 |
| 2026-01-07 | Lee Chan Henry | SVP, General Counsel | Sell | 664 |
| 2025-12-31 | Wang Lai | President, Global Head of R&D | Other | 0 |
| 2025-12-31 | Wang Lai | President, Global Head of R&D | Other | 601,965 |
| 2025-12-31 | Wang Lai | President, Global Head of R&D | Award | 427,895 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,973 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,877 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,512 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,633 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,255 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 2,567 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 5,442 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 7,470 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 40 |
| 2025-12-16 | OYLER JOHN | Director, Chief Executive Officer | Sell | 600 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 2,344 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 121 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 4,949 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 6,389 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 5,829 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 16,318 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 929 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 102,188 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,194 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,791 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 14,163 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 481,533 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 5,118 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 7,722,480 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 9,545,000 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 3,940 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 10,650 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 28,204,115 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Other | 5,141,041 |
| 2025-12-15 | OYLER JOHN | Director, Chief Executive Officer | Sell | 1,896 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,274 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 101 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 133 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Sell | 332 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,729 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 98 |
| 2025-12-11 | Lee Chan Henry | SVP, General Counsel | Convert | 1,313 |